International Alliance for Biological Standardization Covid-19 webinars brought together a broad range
of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries. 

1) The first webinar discussed the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2.

2) The second webinar discussed the use of controlled human infection models to accelerate development and market authorization assessment of a vaccines against SARS-CoV-2.

Reports available on the right panel. 



Please Sign in (or Register) to view further.